ConductScience.org, home

Paper41816596

A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma.

Li J and 6 others. J Gastrointest Oncol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma. Papers, record 41816596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41816596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma.
PubMed
Journal
J Gastrointest Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JJunliang
2Zhang JJunyi
3Wang DDanning
4Shen JJieyi
5Shen CChong
6Zeng WWeiqi
7Wang JJianweihttps://orcid.org/0000-0001-8129-6197

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136604116Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.Gut2023https://conductscience.org/library/papers/36604116PubMed
236755301Metabolic reprogramming in colorectal cancer: regulatory networks and therapy.Cell Biosci2023https://conductscience.org/library/papers/36755301PubMed
331443682Statistical predictions with glmnet.Clin Epigenetics2019https://conductscience.org/library/papers/31443682PubMed
436591255Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.Front Immunol2022https://conductscience.org/library/papers/36591255PubMed
517907291Neural cell adhesion molecule-180 expression as a prognostic criterion in colorectal carcinoma: feasible or not?World J Gastroenterol2007https://conductscience.org/library/papers/17907291PubMed
621746875Stanniocalcin 2 is a negative modulator of store-operated calcium entry.Mol Cell Biol2011https://conductscience.org/library/papers/21746875PubMed
719114008WGCNA: an R package for weighted correlation network analysis.BMC Bioinformatics2008https://conductscience.org/library/papers/19114008PubMed
835070407Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer.J Gastrointest Oncol2021https://conductscience.org/library/papers/35070407PubMed
938369589TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.Sci Rep2024https://conductscience.org/library/papers/38369589PubMed
1029113264Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma.Oncol Lett2017https://conductscience.org/library/papers/29113264PubMed
1139678492Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight.Front Oncol2024https://conductscience.org/library/papers/39678492PubMed
1239773485FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction.Cell Commun Signal2025https://conductscience.org/library/papers/39773485PubMed
1324605266Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity.Oncoimmunology2014https://conductscience.org/library/papers/24605266PubMed
1427007859Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling.Lifetime Data Anal2017https://conductscience.org/library/papers/27007859PubMed
1521210228Nicotine enhances colon cancer cell migration by induction of fibronectin.Ann Surg Oncol2011https://conductscience.org/library/papers/21210228PubMed
1617498763Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells.Toxicol Appl Pharmacol2007https://conductscience.org/library/papers/17498763PubMed
1729929486Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.BMC Cancer2018https://conductscience.org/library/papers/29929486PubMed
1832849517Myeloid-Derived Suppressor Cells in Colorectal Cancer.Front Immunol2020https://conductscience.org/library/papers/32849517PubMed
1934557778clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.Innovation (Camb)2021https://conductscience.org/library/papers/34557778PubMed
2036638198A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.Clin Cancer Res2023https://conductscience.org/library/papers/36638198PubMed

See all 57 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42558886Integrated single-cell and spatial transcriptomic analyses identify TRIP6 as a prognostic and EMT-associated biomarker in colorectal cancer.Front Cell Dev Biol2026https://conductscience.org/library/papers/42558886

Source PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41816596

GET https://conductscience.org/api/papers/v1/41816596/references?page=2